The phrase "assay suite" is correct and usable in written English.
It can be used in contexts related to laboratories, testing facilities, or scientific research where a collection of assays or tests is performed.
Example: "The new assay suite at the lab allows for more efficient testing of various samples."
Alternatives: "testing facility" or "analysis suite".
The new analogs possessed improved RORc cellular potencies with >77-fold selectivity for RORc over other nuclear receptors in our cell assay suite.
A set of JAK2 inhibitors was tested in a high-throughput JAK family cell assay suite and in corresponding purified enzyme assays.
The high-throughput JAK cell assay suite comprises Ba/F3 cells individually expressing translocated ETS leukemia (TEL) fusions of each JAK family member (TEL-JAK Ba/F3) and an AlphaScreen phosphorylated-STAT5 (pSTAT5) immunoassay.
Adopting the high-throughput TEL-JAK Ba/F3 pSTAT5 cell assay suite in lead development paradigms should provide a more meaningful understanding of selectivity and facilitate the development of more selective JAK inhibitors.
Known data gaps in the current assay suite include biological targets in the hypothalamic pituitary gonadal axis, which are covered in the EDSP screening battery.
Variants in the remaining 18 genes in this study were also typed on the MassARRAY® Analyzer 4 System with custom-designed primers using a combination of Agena's Assay Design Suite (ADS) and Primer3 (ref 33).
The primers for PCR and iPLEX reactions were designed using the online Assay design suite 1.0 Sequenom software (available at: www.mysequenom.com/Home) and obtained from IDT (see Table 4) (Integrated DNA Technologies, Carolville, Iowa, USA).
The other 12 SNPs' genotyping was carried out with iPLEX assays (Sequenom, San Diego, CA, USA), which were designed by the Assay Design Suite 1.0 online software.
Together, these assays provide a suite of novel, complementary functional assays with immediate relevance to cancer progression and enabling rapid evaluation of new therapeutic agents, as exemplified below.
In an effort to overcome the sensitivity and analysis shortcomings of STR-based transplant monitoring methods, and to improve upon the current state of the art in qPCR-based chimerism analysis and laboratory workflow, we have created a new assay and software suite.
We therefore developed a new suite of assay technologies that allows comparative assessment of chemical tools for DOT1L in a miniaturized format.
